In Vivo Effect of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutrophilic Expression of CD11b in Septic Neonates: A Randomized Controlled Trial

REFERENCES

• Banerjea MC, Speer CP. The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis [review]. Semin Neonatol. 2002;7:335–349.
   PubMedGoogle Scholar
• Lewis DB, Wilson CB. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 5th ed. Philadelphia: WB Saunders; 2001:25–138.
   Google Scholar
• Urlichs F, Speer CP. Neutrophil function in preterm and term infants. NeoRev. 2004;5:e417–e430.
   Google Scholar
• Gathwala G, Bala H. Colony stimulating factors as adjunctive therapy in neonatal sepsis. Indian J Pediatr. 2006;73:393–394.
   PubMedGoogle Scholar
• Bedford Russell AR, Emmerson AJ, Wilkinson N, et al. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed. 2001;84:F172–F176.
   Google Scholar
• Schulz, KF, Altman DG, Moher D; CONSORT, Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726–732.
   PubMed Web of Science ®Google Scholar
• Elghetany MT, Lacombe F. Physiologic variations in granulocytic surface antigen expression: impact of age, gender, pregnancy, race, and stress. J Leukoc Biol. 2004;75:157–162.
   PubMed Web of Science ®Google Scholar
• Drossou-Agakidou V, Kanakoudi-Tsakalidou F, Sarafidis K, Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial. Eur J Pediatr. 1998;157:583–588.
   PubMedGoogle Scholar
• Murray NA, Roberts IA. Neonatal transfusion practice. Arch, Dis Child, Fetal Neonatal, Ed. 2004;89:F101–F107.
   Web of Science ®Google Scholar
• Luban NL. Neonatal red blood cell transfusions. Curr Opin Hematol. 2002;9:533–536.
   PubMedGoogle Scholar
• Töllner U. Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. Eur J Pediatr. 1982;138:331–337.
   PubMed Web of Science ®Google Scholar
• Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr. 1979;95:89–98.
   PubMed Web of Science ®Google Scholar
• Adib M, Ostadi V, Navaei F, Evaluation of CD11b expression on peripheral blood neutrophils for early detection of neonatal sepsis. Iran J Allergy Asthma Immunol. 2007;6:93–96.
   PubMed Web of Science ®Google Scholar
• Kocherlakota P, La Gamma EF. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics. 1997;100:E6. PMID: 9200380 [PubMed-indexed for MEDLINE].
   PubMed Web of Science ®Google Scholar
• Meisel C, Schefold JC, Pschowski R, Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. 2009;180:640–648.
   PubMed Web of Science ®Google Scholar
• Russell JA. Management of sepsis. N Engl J Med. 2006;355:1699–1713.
   PubMed Web of Science ®Google Scholar
• Carlet J, Cohen J, Calandra T, Sepsis: time to reconsider the concept. Crit Care Med. 2008;36:964–966.
   Google Scholar
• Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med. 2008;14:64–78.
   PubMed Web of Science ®Google Scholar
• Schefold JC, Hasper D, Volk HD, Reinke P. Sepsis: time has come to focus on the later stages. Med Hypotheses. 2008;71:203–208.
   PubMedGoogle Scholar
• Pugin J. Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp. 2007;280:21–27; discussion, 27–36, 160–164.
   PubMedGoogle Scholar
• Hoesel LM, Gao H, Ward PA. New insights into cellular mechanisms during sepsis. Immunol Res. 2006;34:133–141.
   PubMedGoogle Scholar
• Hubel K, Dale DC, Liles WC. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. J Infect Dis. 2002;185:1490–1501.
   PubMed Web of Science ®Google Scholar
• Gillan ER, Christensen RD, Suen Y, A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood. 1994;84:1427–1433.
   PubMed Web of Science ®Google Scholar
• Küçükodük S, Sezer T, Yildiran A, Albayrak D. Randomized, double-blinded, placebo-controlled trial of early administration of recombinant human granulocyte colony-stimulating factor to non-neutropenic preterm newborns between 33 and 36 weeks with presumed sepsis. Scand J Infect Dis. 2002;34:893–897.
   PubMedGoogle Scholar
• Ahmad A, Laborada G, Bussel J, Nesin M. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants. Pediatr Infect Dis J. 2002;21:1061–1065.
   PubMedGoogle Scholar
• Lehrnbecher T. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants]. Z Geburtshilfe Neonatol. 2001;205:167–173.
   PubMedGoogle Scholar
• Bo L, Wang F, Zhu J, Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit Care. 2011; 15:R58. PMID: 21310070 [PubMed - indexed for MEDLINE] PMCID: PMC3221991.
   PubMed Web of Science ®Google Scholar
• Schefold JC. Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock. Crit Care. 2011;15:136. PMID: 21489333 [PubMed - in process] PMCID: PMC3219352 [Available on 2012/3/31].
   PubMedGoogle Scholar
• Carr R, Brocklehurst P, Dore CJ, Modi N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet. 2009;373:226–233.
   PubMed Web of Science ®Google Scholar
• Torossian A, Ruehlmann S, Middeke M, Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte colony-stimulating factor. Anesthesiology. 2003;99:1087–1092.
   PubMedGoogle Scholar
• Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64:328–340.
   PubMed Web of Science ®Google Scholar
• Rosenbloom AJ, Linden PK, Dorrance A, Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest. 2005;127:2139–2150.
   PubMed Web of Science ®Google Scholar
• Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. Sepsis-induced immunosuppression: from bad to worse. Immunol Res. 2001;24:273–287.
   PubMed Web of Science ®Google Scholar
• Nupponen I, Andersson S, Järvenpää AL, Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal Sepsis. Pediatrics. 2001;108:E12. PMID: 11433091 [PubMed - indexed for MEDLINE].
   PubMed Web of Science ®Google Scholar
• Weirich E, Rabin RL, Maldonalda Y, Neutrophil CD11b expression as a diagnostic marker for early-onset neonatal infection. J Pediatr. 1998;132(3 Pt 1):445–451.
   PubMed Web of Science ®Google Scholar
• Miura E, Procianoy RS, Bittar C, A randomized double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early onset sepsis. Pediatrics. 2001;107:30–35.
   PubMed Web of Science ®Google Scholar
• Makhlouf RA, Doron MW, Bose CL, Administration of granulocyte colony-stimulating factor to neutropenic low birth weight infants of mothers with preeclampsia. J Pediatr. 1995;126:454–456.
   PubMed Web of Science ®Google Scholar
• Russell AR, Davies EG, Ball SE, Gordon-Smith E. Granulocyte colony stimulating factor treatment for neonatal neutropenia. Arch Dis Child Fetal Neonat Ed. 1995;72:F53–F54.
   Web of Science ®Google Scholar
• Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch, Dis Child, Fetal Neonatal, Ed. 2003;88:F359–364.
   PubMed Web of Science ®Google Scholar
• Schibler KR, Osborne KA, Leung LY, A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics. 1998;102(1 Pt 1):6–13.
   PubMedGoogle Scholar
• Carr R, Modi N, Doré C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane, Database Syst, Rev. 2003;(3): CD003066.
   Google Scholar
• Kuhn P, Messer J, Paupe A, A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia. J Pediatr. 2009;155:324–330, e321.
   PubMedGoogle Scholar